EP Patent

EP3318565B1 — Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamides

Assigned to Pfizer Inc · Expires 2021-04-14 · 5y expired

What this patent protects

Patent listed against Litfulo.

Drugs covered by this patent

Patent Metadata

Patent number
EP3318565B1
Jurisdiction
EP
Classification
—
Expires
2021-04-14
Drug substance claim
No
Drug product claim
No
Assignee
Pfizer Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.